Allergan Inc. (NYSE: AGN) was raised to Buy from Neutral at Citigroup.
Check Point Software (NASDAQ: CHKP) was started with a Buy rating and an $80 price target at Sterne Agee.
Chevron Corp. (NYSE: CVX) was raised to Strong Buy from Outperform with a $132 price target at Raymond James.
Devon Energy Corp. (NYSE: DVN) was raised to Outperform from Neutral and the price target was raised to $76 from $73 by Credit Suisse.
Gap Inc. (NYSE: GPS) was raised to Buy from Neutral at UBS.
GlycoMimetics Inc. (NASDAQ: GLYC) saw its quiet period end. The biotech outfit was started with a Buy rating at Canaccord Genuity, started as Buy at Stifel Nicolaus and started as Buy at Jefferies.
Google Inc. (NASDAQ: GOOG) was reiterated as Buy and the price target was raised to $1,350 at Argus.
Helmerich & Payne Inc. (NYSE: HP) was downgraded to Underperform from Neutral by Credit Suisse.
LifeLock Inc. (NYSE: LOCK) was started as Buy at Sterne Agee.
Merck & Co. Inc. (NYSE: MRK) was raised to Buy from Neutral at SunTrust Robinson Humphrey.
Microsoft Corp. (NASDAQ: MSFT) was started as Neutral with a $40 price target at Sterne Agee.
Newmont Mining Corp. (NYSE: NEM) was downgraded to Neutral from Overweight by J.P. Morgan.
Oracle Corp. (NYSE: ORCL) was started with a Neutral rating and a $40 price target at Sterne Agee.
Pfizer Inc. (NYSE: PFE) was upgraded to Buy from Hold and the price target was raised to $38 from $33 at Jefferies.
Symantec Corp. (NASDAQ: SYMC) was started as Neutral at Sterne Agee.
WisdomTree Investments (NASDAQ: WETF) was raised to Buy from Neutral at Bank of America Merrill Lynch.
Zynga Inc. (NASDAQ: ZNGA) was raised to Buy from Neutral and its target price was lifted to $4 from $6 at UBS. Keep in mind that this call was a day after Merrill Lynch downgraded Zynga to Underperform.
Top Gaining Stocks
Top Losing Stocks